API
< Back to situations

[ORGANIZATION]

ESMO

Featured in 9 tracked stories · first seen

Situations

[ACTIVE] [HEALTH] [US] [IT] [GR]

FDA and EMA approval progress for Rasonque pancreatic cancer

49 clusters · 334 sources · last updated

Latest: Daraxonrasib drug shows promise in treating metastatic pancreatic cancer

On 26 August 2026, the U.S. Food and Drug Administration (FDA) granted expedited approval to daraxonrasib, marketed as Rasonque, for treating adults with metastatic pancreatic ductal adenocarcinoma (PDAC). Developed by R

[ACTIVE] [HEALTH] [IT]

Italian healthcare reform and regional developments

13 clusters · 147 sources · last updated

Latest: Italy healthcare: regional updates on digital records and oncology services

Discussions regarding the Italian healthcare system have increasingly focused on preventative measures, risk management, and structural integration. Political figures have called for a shift from a treatment-only model t

[ACTIVE] [HEALTH] [US] [AU] [ES]

mRNA technology and personalized cancer vaccine research

4 clusters · 121 sources · last updated

Latest: Moderna cancer vaccine reduces melanoma recurrence risk by 42%

Recent medical research highlights significant progress in using messenger RNA (mRNA) technology to develop personalized cancer vaccines. These vaccines utilize a patient’s specific tumor mutations or neoantigens to trai

[QUIET] [HEALTH] [DE] [ES] [GR]

Lung cancer screening and treatment advancements

2 clusters · 2 sources · last updated

Latest: Lung cancer advancements focus on early diagnosis and patient care

Developments in lung cancer management are increasingly focused on early detection through screening and the integration of innovative therapies. In Germany, statutory health insurance has begun covering low-dose CT scan

[QUIET] [HEALTH] [US] [DE] [ES]

Sacituzumab tirumotecan endometrial cancer research

2 clusters · 7 sources · last updated

Latest: Scientific research explores brain health, nutrition, and cognitive function

Clinical trial results for the experimental antibody-drug conjugate sacituzumab tirumotecan (sac-TMT) indicate significant improvements for patients with advanced or recurrent endometrial cancer. Data from the Phase 3 Tr

[QUIET] [HEALTH] [DE] [KR] [NZ]

Cancer treatment research and clinical updates

2 clusters · 5 sources · last updated

Latest: Medical researchers identify new indicators for cancer treatment efficacy

Recent medical developments have introduced new standards and indicators for cancer treatment. Updated S3 guidelines for cervical carcinoma now recommend platinum and taxane-based chemotherapy combined with Pembrolizumab

Also covered in